Tradestie Institutional Equity Comparison Engine

BDMD vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BDMD counters with relative strength in Valuation. Fundamentally, BDMD trades at 0.7x Forward P/E with -58.5% operating margin (+24.6% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BDMD sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BDMD
BDMD 0.7x vs DCTH N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin -58.5% vs 5.2% ยท YoY +24.6% vs +70.7%
Momentum & Technical Winner DCTH
1Y -93.1% vs +128.6% ยท 52W Pos 0% vs 80%
Options & Structure Winner DCTH
BREAKDOWN (N/A IV) vs BREAKOUT (43rd %ile IV)
BDMD NASDAQ
Baird Medical Investment Holdings Ltd Ordinary Share
Surgical & Medical Instruments & Apparatus
$0.09
-2.54% 1D
Market Cap $3.4M
1M Return -84.42%
1Y Return -93.11%
Forward P/E 0.7x
Unified AI Score
49.5 / 100 HOLD
Tech 60.0 Fund 58.0 Flow 50.0 Mom 65.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BDMD -93.11% DCTH +128.57% Spread: +221.68 pp (DCTH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BDMD TTM Op. Margin: -58.5% DCTH TTM Op. Margin: 5.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDMD vs DCTH. Trailing 12-month operating profitability (BDMD -58.5% vs DCTH 5.2%) and valuation multiples (BDMD 0.7x vs DCTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BDMD (3) vs DCTH (7)
Institutional Metric BDMD DCTH Criterion Row Winner
Market Capitalization Scale $3.4M $743.8M Larger Scale DCTH
Trailing P/E Ratio Valuation 0.7x 133.6x Lower Multiple BDMD
Forward P/E Ratio Valuation 0.7x N/M Lower Multiple BDMD
Revenue Growth (YoY) Growth +24.6% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability -58.5% 5.2% Higher Margin DCTH
Net Profit Margin Profitability -65.1% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency -46.0% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 0% ($0โ€“$4) 80% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 0.20ฮฒ ยท 302% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk DCTH
Unified Institutional Score Composite Signal 49.5 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite BDMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BDMD vs DCTH Buy Guide
BDMD BREAKDOWN
176d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BDMD nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.